Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Portable Paper Machine Can Diagnose Disease Cheaply

By LabMedica International staff writers
Posted on 04 Aug 2015
The unparalleled sensitivity and specificity of nucleic acid amplification tests (NAATs), led by those based on polymerase chain reaction (PCR), have become increasingly available in the developed world for the diagnosis of infectious, genetic, and other diseases.

In countries where resources are limited, performing the same diagnostics is far more challenging, so a portable, low-cost “paper machine” for point-of-care detection of infectious diseases, genetic conditions and cancer has been developed to address this problem. More...


Scientists at Diagnostics For All (Cambridge, MA, USA) collaborating with Harvard University (Cambridge, MA; USA) developed a device that integrates sample preparation and loop-mediated isothermal amplification (LAMP) with end point detection using a hand-held UV source and camera phone. The prototype device integrates paper microfluidics and a multilayer structure, or a “paper machine” that allows a central patterned paper strip to slide in and out of fluidic path and thus allows introduction of sample, wash buffers, amplification master mix, and detection reagents with minimal pipetting, in a hand-held, disposable device intended for point-of-care use in resource-limited environments.

The device creates a dynamic seal that prevents evaporation during incubation at 65 °C for one hour. This interval is sufficient to allow a LAMP reaction for the Escherichia coli maltoporin (malB) gene to proceed with an analytical sensitivity of one double-stranded DNA target copy. Starting with human plasma spiked with whole, live E. coli cells, the team demonstrated full integration of sample preparation with LAMP amplification and end point detection with a limit of detection of five cells. Further, it shows that the method used to prepare sample enables concentration of DNA from sample volumes commonly available from fingerstick blood draw.

The authors noted that using materials that cost a less than USD 2 total, they condensed sample preparation, DNA analysis and detection steps into a hand-held paper machine. It successfully determined whether as few as five cells of E. coli were present in test samples. The results can be read using ultraviolet light and a smartphone camera. The investigators said they are further refining the machine to make it even simpler to use. The study was published on June 23, 2015, in the journal Analytical Chemistry.

Related Links:

Diagnostics for All
Harvard University 



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.